Bibliography

  • Antczak, A., et al, 2002. Increased Exhaled Cysteinyl-Leukotrienes and 8-Isoprostane in Aspirin- Induced Asthma. Am J Respir Crit Care Med 166: 301-306
  • Baraldi, E., et al, 2003. Cysteinyl Leukotrienes and 8-Isoprostane in Exhaled Breath Condensate of Children with Asthma Exacerbations. Thorax 58:505-509.
  • Barham, J.B., et al, 2000. Addition of eicosapentaenoic acid to gamma-linolenic acid-supplemented diets prevents serum arachidonic acid accumulation in humans. J Nutr 130: 1925-1931.
  • Bisgaard, H., et al, 1985. Production of leukotrienes in human skin and conjunctival mucosa after specific allergen challenge. Allergy 40: 417-423.
  • Brain, S.D., and Williams TJ. 1990. Leukotrienes and inflammation. Pharmacol Ther 46:57-66.
  • Busse, W.W., 1996. The role of leukotrienes in asthma and allergic rhinitis. Clin Exp Allergy 26: 868-879.
  • Busse, W.W., 1998. Leukotrienes and inflammation. Am J Respir Crit Care Med 157 (6 Pt 2): S210-3.
  • Busse, W.W., and Kraft M. 2005. Cysteinyl leukotrienes in allergic inflammation. Chest. 127:1312.
  • Carraro, S.C., et al, 2005. Exhaled breath condensate cysteinyl leukotrienes are increased in children with exercised-induced bronchoconstriction. J Allergy Clin Immunol 115: 764-770.
  • Donnelly, AL et al, 1995. The leukotriene D4- receptor antagonist, ICI 204,219, relieves symptoms of acute seasonal allergic rhinitis. Am J Respir Crit Care Med 151(6):1734.
  • Mita, H., Yui, Y., Taniguchi, N., Yasueda, H., Shida, T., 1985. Increased activity of 5-lipoxygenase in polymorphonuclear leukocytes from asthmatic patients. Life Sci 37:907–914
  • O'Byrne, P.M., 1997. Leukotrienes in pathogenesis of asthma. Chest 111(2 Suppl.): 27s.
  • Peters-Golden, M. and Henderson, W.R. Jr., 2005. The role of leukotrienes in allergic rhinitis. Ann Allergy Asthma Immunol 94(6):609-618.
  • Sampson, A.P., et al, 1992. Enhanced leukotriene synthesis in leukocytes of atopic and asthmatic subjects. Br J Clin Pharmacol 33:423.
  • Spergel, J.M., and Paller A.S.S., 2003. Atopic dermatitis and the atopic march. J Allergy Clin Immunol. 112:S118-S127.
  • Steinke, J.W., and Boorish, L., 2004. Leukotriene receptors in rhinitis and sinusitis. Curr Allergy Asthma Rep 4: 217-223.
  • Surette, M.E., et al, 2003a. Inhibition of Leukotriene Synthesis, Pharmacokinetics, and Tolerability of a Novel Dietary Fatty Acid Formulation in Healthy Adult Subjects. Clinical Therapeutics 25(3):948- 971.
  • Surette, M.E., et al, 2003b. Inhibition of Leukotriene Synthesis by a Novel Dietary Fatty Acid Formulation in patients with Atopic asthma: A randomized, placebo-controlled, parallel-group, prospective trial. Clinical Therapeutics 25(3):972-979
  • Talbot, S.F., et al., 1985. Accumulation of leukotriene C4 and histamine in human allergic skin reactions. J Clin Invest. 76:650.
  • Wenzel, S.E., 2003. The role of leukotrienes in asthma. Prost. Leuk Essent Fatty Acids 69:145-155.
  • Zanconato, S., et al, 2004. Leukotrienes and 8-isoprostane in exhaled breath condensate of children with stable and unstable asthma. J Allergy Clin Immunol. 113:257-63.
  • Zsuzsanna, C., et al, 2002. Increased Leukotrienes in Exhaled Breath Condensate in Childhood Asthma. Am J Respir Crit Care Med 166:1345-1349.
  • Bisgaard, H., 2001, Leukotriene Modifiers in Pediatric Asthma Management, Pediatrics 107:381- 390.
  • Eapen, S.S. and Busse, W.W. 2002. Asthma. In: Zweiman, B. and Schwartz, L.B. eds. Inflammatory Mechanisms in Allergic Disease. Marcel Dekker, New York
  • Pynaert, G., et al, 1999, Cysteinyl Leukotrienes Mediate Histamine Hypersensitivity Ex Vivo by Increasing Histamine Receptor Numbers, Molecular Medicine 5:685-692.
  • Rackal, J.M. and Vender, R.B. 2004, The Treatment of Atopic Dermatitis and Other Dermatoses with Leukotriene Antagonists, Skin Therapy Letter 9(2):1-5.
  • Julemont, F., et al, 2003, Recent Developments in 5-Liboxygenase Inhibitors, Expert Opinion Ther. Patents 13(1):1-13.
  • Iverson, L et al, 1992. Effects of dihomogammalinolenic acid and 15-lipoxygenase metabolite on eicosanoid metabolism by human mononuclear leukocytes in vitro: selective inhibition of the 15-LO pathway. Arch Dermatol Res 284:222
  • Guichardant, M. et al, 1993. Stearidonic acid, an inhibitor of the 5-lipoxygenase pathway. A comparison with timnodonic and dihomogammalinolenic acid. Lipids 28: 321-324.
  • Miller, C.C. et al, 1991. Dietary supplementation with ethyl ester concentrates of fish oil (n-3) and borage oil (n-6) polyunsaturated fatty acids induces epidermal generation of local putative anti-inflammatory metabolites. J Invest Dermatol 96: 98-103.
  • Chilton-Lopez, T., et al, 1996, Metabolism of GLA in Human Neutrophils, The Journal of Immunology 156:2941-2947.
  • Johnson, M.M., et al, 1997, Dietary Supplementation with Gamma-Linolenic Acid Alters Fatty acid Content and Eicosanoid Production in Healthy Humans, J. Nutr 127:1435-1444.
  • Ziboh, V.A., and Fletcher, M.P., 1992. Dose-Response Effects of Dietary Gamma-Linolenic Acid- Enriched Oils On Human Polymorphonuclear-Neutrophil Biosynthesis of Leukotriene B4. Am J Clin Nutr 55:39-45.
  • Chapkin, R.S., Akoh, C.C., and Miller, C.G., 1991. Influence of dietary n-3 fatty acids on mecrophage glycerophospholiipid molecular species and peptidoleukotriene synthesis. J Lipid Res 32: 1205-1213.
  • Lands, W.E.M., 1992. Biochemistry and physiology of n-3 fatty acids. FASEB J 6: 2530-2536.
  • Stulnig, T.M., 2003. Immunomodulation by Polyunsaturated Fatty Acids: Mechanisms and Effects, Int Arch Allergy Immunol 132:310-321.
  • Nassar, B.A, et al, 1986. The influence of dietary manipulation with n-3 and n-6 fatty acids on liver and plasma phospholipid fatty acids in rats. Lipids 21: 652-656.
  • Schwartz, J., 2000. Role of Polyunsaturated Fatty Acids in Lung Disease, American Journal Clinical Nutrition 71:393S-396S.
  • Broughton, K.S., et al, 1997, Reduced Asthma Symptoms with n-3 Fatty Acid Ingestion are Related to 5-Series Leukotriene Production, American Journal of Clinical Nutrition 65:1011-1017.
  • Stenius-Aarniala, B., et al, 1989. Evening primrose oil and fish oil are ineffective as supplementary treatment of bronchial asthma. Ann Allergy 62: 534-537.
  • Peat, J.K., et al, 2004. Three-year outcomes of dietary fatty acid modification and house dust mite reduction in the Childhood Asthma Prevention Study. J Allergy Clin Immunol 114: 807-813.
  • Mickleborough, T.D., et al, 2003, Fish Oil Supplementation Reduces Severity of Exercise-Induced Bronchoconstriction in Elite Athletes, Am J Respir Crit Care Med 168:1181-1189.
  • Garaiova, I., et al, 2007. A randomized cross-over trial in healthy adults indicating improved absorption of omega-3 fatty acids by pre-emulsification. Nutr. J 6: 4
  • Surette, M.E., et al, 2007. A medical food that reduces leukotriene biosynthesis improves quality of life in adult asthmatic subjects. Manuscript in preparation.